Zimbabwe has withdrawn from negotiations on a $367 million bilateral health agreement with the United States, citing concerns over the sharing of sensitive health data. Government spokesperson Nick Mangwana described the proposed arrangement as “unequal,” noting that Zimbabwe would have been asked to provide its biological resources and health data without any guarantee of access to resulting medical innovations, such as vaccines, diagnostics, or treatments. He also highlighted that the U.S. would not be sharing its own epidemiological data in return.
The proposed agreement would have provided $367 million over five years for programs including HIV/AIDS treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness. Following Zimbabwe’s withdrawal, the U.S. embassy in Harare announced that Washington’s health assistance in the country would now be wound down. U.S. Ambassador Pamela Tremont described the process as “difficult and regrettable.”
Mangwana emphasized that the financial support came with conditions that threatened national security, data sovereignty, and access to strategic resources, fundamentally changing the nature of the partnership. While he did not specify the resources in question, Zimbabwe is a significant producer of minerals such as gold, platinum, and lithium, and announced the immediate suspension of exports of all raw minerals and lithium concentrates.
The decision follows a broader regional trend, with a Kenyan court suspending a $1.6 billion U.S. health funding agreement over similar concerns about citizens’ data. Mangwana stressed that Zimbabwe’s move is not anti-American but reflects Africa’s growing insistence on equitable partnerships rather than arrangements perceived as patronage.
